6896 Stock Overview
An investment holding company, manufactures and sells pharmaceutical, healthcare food, and other products in the People’s Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Golden Throat Holdings Group Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$3.09 |
| 52 Week High | HK$4.09 |
| 52 Week Low | HK$2.90 |
| Beta | -0.14 |
| 1 Month Change | -0.96% |
| 3 Month Change | -1.28% |
| 1 Year Change | -6.93% |
| 3 Year Change | 90.74% |
| 5 Year Change | 159.66% |
| Change since IPO | -36.55% |
Recent News & Updates
Recent updates
The Trend Of High Returns At Golden Throat Holdings Group (HKG:6896) Has Us Very Interested
Jun 14
Here's Why Shareholders May Want To Be Cautious With Increasing Golden Throat Holdings Group Company Limited's (HKG:6896) CEO Pay Packet
May 29Estimating The Intrinsic Value Of Golden Throat Holdings Group Company Limited (HKG:6896)
May 11Is Golden Throat Holdings Group (HKG:6896) Using Too Much Debt?
Apr 28Returns On Capital At Golden Throat Holdings Group (HKG:6896) Paint A Concerning Picture
Apr 13Golden Throat Holdings Group Company Limited's (HKG:6896) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Mar 05What Is The Ownership Structure Like For Golden Throat Holdings Group Company Limited (HKG:6896)?
Feb 16
Is Golden Throat Holdings Group Company Limited (HKG:6896) A Risky Dividend Stock?
Jan 26Should You Be Adding Golden Throat Holdings Group (HKG:6896) To Your Watchlist Today?
Jan 04Golden Throat Holdings Group's (HKG:6896) Stock Price Has Reduced 68% In The Past Five Years
Dec 14Golden Throat Holdings Group Company Limited's (HKG:6896) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Nov 25Shareholder Returns
| 6896 | HK Personal Products | HK Market | |
|---|---|---|---|
| 7D | -0.3% | -0.8% | -0.5% |
| 1Y | -6.9% | 19.3% | 19.9% |
Return vs Industry: 6896 underperformed the Hong Kong Personal Products industry which returned 19.3% over the past year.
Return vs Market: 6896 underperformed the Hong Kong Market which returned 19.9% over the past year.
Price Volatility
| 6896 volatility | |
|---|---|
| 6896 Average Weekly Movement | 3.1% |
| Personal Products Industry Average Movement | 7.1% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in HK Market | 18.6% |
| 10% least volatile stocks in HK Market | 4.1% |
Stable Share Price: 6896 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 6896's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1956 | 874 | Yong Zeng | www.goldenthroat.com |
Golden Throat Holdings Group Company Limited, an investment holding company, manufactures and sells pharmaceutical, healthcare food, and other products in the People’s Republic of China. The company offers Golden Throat Lozenges over-the-counter medicine to relieve symptoms of sore and dry throat, and hoarse voice caused by acute pharyngitis. It also provides Golden Throat Lozenge series products, which include Dule Lozenges; sugar-free Dule Lozenges; and other sugar free flavours, such as orange, fructus momordicae, chrysanthemum, American ginseng, and hawthorn.
Golden Throat Holdings Group Company Limited Fundamentals Summary
| 6896 fundamental statistics | |
|---|---|
| Market cap | HK$2.28b |
| Earnings (TTM) | HK$279.19m |
| Revenue (TTM) | HK$1.07b |
8.2x
P/E Ratio2.1x
P/S RatioIs 6896 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6896 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.01b |
| Cost of Revenue | CN¥278.82m |
| Gross Profit | CN¥727.43m |
| Other Expenses | CN¥465.22m |
| Earnings | CN¥262.21m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.35 |
| Gross Margin | 72.29% |
| Net Profit Margin | 26.06% |
| Debt/Equity Ratio | 39.9% |
How did 6896 perform over the long term?
See historical performance and comparisonDividends
18.6%
Current Dividend Yield154%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 11:34 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Golden Throat Holdings Group Company Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Wai Ming Kong | DBS Vickers Research |